Board meeting on 30 October 2026 to consider and approve unaudited Q2 FY2027 results
Ajanta Pharma has informed the exchanges that its Board of Directors will meet on Friday, 30 October 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Friday, 30 October 2026
- Period of Financial Results
- second quarter and half year ended 30 September 2026
- Intimation Date
- 15 October 2026
Board meeting on 30 October 2026
- Ajanta Pharma has informed BSE and NSE that a meeting of its Board of Directors will be held on Friday, 30 October 2026.
- The board will, inter-alia, consider and approve the unaudited consolidated and standalone financial results of the company for the second quarter and half year ended 30 September 2026.
- The intimation is dated 15 October 2026 and is signed by Gaurang Shah, Sr. VP – Legal & Company Secretary.
- The company's shares are listed on BSE under scrip code 532331 and on NSE under the symbol AJANTPHARM EQ.
What this announcement is
This is a scheduling notice. Its purpose is to inform the market of the date on which the company's Q2 FY2027 numbers will be placed before the board for approval. The quarterly and half-yearly figures are approved and published separately from this notice.
What to watch
- The results themselves, which are taken up for approval at the meeting on 30 October 2026.
- Two sets of results are on the agenda — standalone and consolidated — so an investor will see the company's own numbers as well as the group numbers that include its other entities.
- The period covered is the second quarter as well as the half year ended 30 September 2026.
How such notices are generally received
These are routine calendar announcements. They carry no view on the company's performance and simply mark the date on which the quarterly numbers are taken on record by the board. Investors usually treat them as a reminder of when to expect the results.
Also from Ajanta Pharma
Promoter trust pledges 30,000 shares (0.02%) after top-up call on share price fall
21 Oct 2026
Ajanta Pharma to release Q2 FY2027 unaudited results on 30 Oct 2026; earnings conference call at 16:00 IST
15 Oct 2026
Promoter Aayush Agrawal creates pledge on 4,60,000 shares for NCD issue
6 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.